• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis.

作者信息

Hayward-Koennecke Helen, Reindl Markus, Martin Roland, Schippling Sven

机构信息

From Neuroimmunology and MS Research, Neurology Clinic (H.H.-K., R.M., S.S.), University Zurich, Switzerland; and Clinical Department of Neurology (M.R.), Medical University of Innsbruck, Austria.

出版信息

Neurology. 2019 Apr 16;92(16):765-767. doi: 10.1212/WNL.0000000000007312. Epub 2019 Mar 20.

DOI:10.1212/WNL.0000000000007312
PMID:30894449
Abstract
摘要

相似文献

1
Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis.托珠单抗治疗重度复发性抗髓鞘少突胶质细胞糖蛋白相关视神经炎
Neurology. 2019 Apr 16;92(16):765-767. doi: 10.1212/WNL.0000000000007312. Epub 2019 Mar 20.
2
Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.抗髓鞘少突胶质细胞糖蛋白抗体阳性视神经炎的诊断与治疗
Jpn J Ophthalmol. 2018 Mar;62(2):101-108. doi: 10.1007/s10384-018-0561-1. Epub 2018 Feb 14.
3
Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies.利妥昔单抗对急性播散性脑脊髓炎有效，该疾病之后出现了伴有抗髓鞘少突胶质细胞糖蛋白抗体的复发性视神经炎。
Brain Dev. 2018 Aug;40(7):607-611. doi: 10.1016/j.braindev.2018.03.011. Epub 2018 Apr 13.
4
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.髓鞘少突胶质细胞糖蛋白（MOG）自身抗体作为严重视神经炎和亚临床视网膜轴突退变的潜在标志物。
J Neurol. 2017 Jan;264(1):139-151. doi: 10.1007/s00415-016-8333-7. Epub 2016 Nov 14.
5
Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.水通道蛋白-4 和髓鞘少突胶质细胞糖蛋白自身抗体状态预测复发性视神经炎的结局。
Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.
6
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.伴有髓鞘少突胶质细胞糖蛋白抗体、水通道蛋白4抗体的视神经炎与多发性硬化症的影像学鉴别
Mult Scler. 2016 Apr;22(4):470-82. doi: 10.1177/1352458515593406. Epub 2015 Jul 10.
7
Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France.抗髓鞘少突胶质细胞糖蛋白（MOG）抗体谱障碍患者的视神经炎：来自法国一个大型多中心队列的MRI和临床特征
J Neurol. 2017 Oct;264(10):2173-2175. doi: 10.1007/s00415-017-8615-8. Epub 2017 Sep 15.
8
Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.视神经炎治疗试验中患者的髓鞘少突胶质细胞糖蛋白和水通道蛋白4-IgG的患病率
JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.
9
Tocilizumab in MOG-antibody spectrum disorder: a case report.托珠单抗治疗 MOG 抗体谱疾病：一例报告。
Mult Scler Relat Disord. 2019 Jan;27:312-314. doi: 10.1016/j.msard.2018.11.012. Epub 2018 Nov 13.
10
MOG antibody-associated encephalomyelitis/encephalitis.髓鞘少突胶质细胞糖蛋白抗体相关脑脊髓炎/脑炎
Mult Scler. 2019 Oct;25(11):1427-1433. doi: 10.1177/1352458519837705. Epub 2019 Mar 25.

引用本文的文献

1
Interleukin-6 targeting antibodies for the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): A review of current literature.用于治疗髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）的白细胞介素-6靶向抗体：当前文献综述
AIMS Neurosci. 2025 May 8;12(2):113-139. doi: 10.3934/Neuroscience.2025008. eCollection 2025.
2
Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).治疗髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）的新原则
Curr Treat Options Neurol. 2023 Nov;25(11):437-453. doi: 10.1007/s11940-023-00776-1. Epub 2023 Nov 22.
3
Biomarkers for diagnosis and prognosis of myelin oligodendrocyte glycoprotein antibody-associated disease - review article.
用于诊断和预测髓鞘少突胶质细胞糖蛋白抗体相关疾病的生物标志物——综述文章
Front Immunol. 2025 Jun 6;16:1594960. doi: 10.3389/fimmu.2025.1594960. eCollection 2025.
4
Clinical characteristics of overlapping syndrome in patients with GFAP-IgG and MOG-IgG: a case series of 8 patients and literature review.GFAP-IgG 和 MOG-IgG 阳性重叠综合征患者的临床特征：8 例病例系列及文献复习。
J Neurol. 2024 Oct;271(10):6811-6821. doi: 10.1007/s00415-024-12633-5. Epub 2024 Aug 27.
5
Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022.视神经炎的绘图知识领域的可视化和分析：2013 年至 2022 年的文献计量研究。
Int Ophthalmol. 2024 Feb 12;44(1):57. doi: 10.1007/s10792-024-02948-7.
6
Tocilizumab treatment in MOGAD: a case report and literature review.托珠单抗治疗 MOGAD：病例报告及文献复习。
Neurol Sci. 2024 Apr;45(4):1429-1436. doi: 10.1007/s10072-023-07189-7. Epub 2023 Nov 27.
7
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases.中枢神经系统炎性脱髓鞘疾病的抗 IL-6 治疗。
Front Immunol. 2022 Oct 27;13:966766. doi: 10.3389/fimmu.2022.966766. eCollection 2022.
8
Update on glial antibody-mediated optic neuritis.神经胶质抗体相关性视神经炎的最新进展。
Jpn J Ophthalmol. 2022 Sep;66(5):405-412. doi: 10.1007/s10384-022-00932-1. Epub 2022 Jul 27.
9
Recurrent Optic Perineuritis With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated With Granulomatous Polyangiitis.复发性视神经周围炎伴髓鞘少突胶质细胞糖蛋白抗体相关疾病合并肉芽肿性多血管炎。
Cureus. 2022 May 23;14(5):e25239. doi: 10.7759/cureus.25239. eCollection 2022 May.
10
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies.视神经炎恢复模式的纵向比较：针对髓鞘少突胶质细胞糖蛋白（MOG）抗体血清阳性以及水通道蛋白4（AQP4）抗体血清阳性或双抗体血清阴性的情况
J Ophthalmol. 2022 Mar 22;2022:4951491. doi: 10.1155/2022/4951491. eCollection 2022.